

1 lozenge pill contains antibodies to a prostate-specific antigen, affinity-purified (administered as a water-alcohol mixture of the active form of the active substance) 0.003 g,
40 or 100 pcs. packaged.
Anti-inflammatory, antidysuric. Afalaza reduces the phenomena of edema and inflammation in the prostate gland, normalizes its functional state. Improves urodynamics, reduces the amount of residual urine, normalizes the tone of the lower urinary tract, helps reduce dysuric disorders.
Benign prostatic hyperplasia of stage I and II;
in the complex treatment of acute and chronic prostatitis (as an anti-inflammatory and analgesic);
dysuric disorders (frequent urge to urinate, including nocturnal, difficulty urinating, pain or discomfort in the perineal region), including accompanying benign prostatic hyperplasia of stage I and II and acute and chronic prostatitis.
Increased individual sensitivity to the components of the drug.
Inside, 2 pills per reception (keep the pill in the mouth until completely dissolved). Outside the meal. Afalaza should be taken twice a day, morning and evening (after and before sleep). The recommended duration of the drug is 16 weeks.
The composition of Afalaza includes lactose, in connection with which it is not recommended to appoint it to patients with congenital galactosemia, malabsorption syndrome of glucose or galactose, or in congenital lactase deficiency.
In the dark place at a temperature of no higher than 25 ° C.
Afala